Representative Publications

View All PubMed Entries


Elsaid MY, Capitini CM, Diamond CA, Porte M, Otto M, DeSantes KB: Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease. Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.153. [Epub ahead of print] PMID: 27295273

Li Y, Bouchlaka MN, Wolff J, Grindle KM, Lu L, Qian S, Zhong X, Pflum N, Jobin P, Kahl BS, Eickhoff JC, Wuerzberger-Davis SM, Miyamoto S, Thomas CJ, Yang DT, Capitini CM, Rui L: FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma. Oncogene. 2016 May 9. doi: 10.1038/onc.2016.155. [Epub ahead of print] PMID: 27157620

Bouchlaka MN, Ludwig KD, Gordon JW, Kutz MP, Bednarz B, Fain SB, Capitini CM: 19F-MRI for monitoring human NK cells in vivo. Oncoimmunology. 2016 Feb 18;5(5):e1143996, DOI: 10.1080/2162402X.2016.1143996

McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. NK cell-based immunotherapies in Pediatric Oncology. J Pediatr Hematol Oncol. 2015 Mar;37(2):79-93. PMID: 25590232.

Capitini CM, Romero P. JITC launches a new section: commentary and editorials. J Immunother Cancer. 2015 Jun 24; 3:28. PMID: 26110058.

Capitini CM Otto M DeSantes KB Sondel PM. Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol. 2014;10(9):1659-7.8. PMID: 25145434.

Capitini CM, Nasholm NM, Chien CD, Larabee SM, Qin H, Song YK, Klover PJ, Hennighausen L, Khan J, Fry TJ. Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD. Blood. 2014 Sep 18;124(12):1976-86. PMID: 25079358.

Capitini CM, Redmond WL and Shafer-Weaver KA. Professional development session for early career scientists at SITC 2012. Journal for Immunotherapy of Cancer 2013, 1(6). PMID: 25742323.

Shand JC, Qin H, Nasholm N, Capitini CM, Fry TJ. Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T-cells. Biol Blood Marrow Transplant. 2013 Oct 17. PMID: 24141010.

Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Gendron-Fitzpatrick A, Gumperz JE . Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2013 Sep;19(9):1310-22. PMID: 23806772.

Capitini CM, Nasholm NM, Duncan BB, Guimond M Fry TJ . Graft-versus-Host Disease Impairs Vaccine Responses through Decreased CD4+ and CD8+ T Cell Proliferation and Increased Perforin-Mediated CD8+ T Cell Apoptosis. J Immunol. 2013 Feb 1;190(3):1351-9. PMID: 23275602.

Capitini CM, Gottschalk S, Brenner M, Cooper LJN, Handgretinger R, Mackall CL. 2011. Highlights of the second international conference in pediatric oncology. Pediatr Hematol Oncol. 2011 Sep;28(6):459-60.

Capitini CM*, Davis JP*, Larabee SM, Herby S, Nasholm NM, Fry TJ. 2011. Extracorporeal photopheresis attenuates murine GVHD via bone marrow-derived IL-10 and preserves responses to dendritic cell vaccination, Biology of Blood and Marrow Transplantation 2011 Jun;17(6):790-9. * = Co-first authors. PMC3087832.

Temple LM, Miyamoto DM, Mehta M, Capitini CM, Von Stetina S, Barnes HJ, Christensen VL, Horton JR, Spears PA, Orndorff PE. 2010. Identification and characterization of two Bordetella avium gene products required for hemagglutination. Infection and Immunity 2010 Jun;78(6):2370-6. PMC2876549.

Wayne AS, Capitini CM, Mackall CL. 2010. Immunotherapy of Childhood Cancer: From Biologic Understanding to Clinical Application. Current Opinion in Pediatrics 2010 Feb;22(1):2-11. PMC2845444.

Capitini CM, Mackall CL, Wayne AS. 2010. Immune-based therapeutics for pediatric cancer.  Expert Opinion on Biological Therapy 2010 Feb;10(2):163-78. PMC2809805.

Capitini CM, Fry TJ, Mackall CL. 2009. Cytokines as adjuvants for vaccine and cellular therapies for cancer. American Journal of Immunology 2009; 5:65-83. PMC2826803

Capitini CM, Chisti AA, Mackall CL. 2009. Modulating T cell Homeostasis with IL-7: Preclinical and Clinical Studies.  Journal of Internal Medicine 2009 Aug:266 (2):141-153. PMC2797310.

Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ. 2009. Bone marrow deficient in gamma interferon signaling selectively abrogates GVHD and enhances a tumor-specific GVT effect. Blood 2009 May 14;113 (20):5002-5009. PMC2686147.

Capitini CM, Cooper LJN, Egeler RM, Handgretinger R, Locatelli F, Sondel PM, Mackall CL. 2009. Highlights of the first international “Immunotherapy in pediatric oncology: progress and challenges” meeting.  Journal of Pediatric Hematology/Oncology 2009 April:31(4):227-44. PMC2714285.

Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, Murphy WJ, Bennett M. 2001. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 2001 May 15;97 (10):31:32-7.